首页 | 本学科首页   官方微博 | 高级检索  
     

腺苷A1受体激动剂减轻糖尿病并发抑郁症大鼠的认知功能障碍
引用本文:杨蕙,柳卓,孟盼,杜青,王宇红,刘检,杨琴. 腺苷A1受体激动剂减轻糖尿病并发抑郁症大鼠的认知功能障碍[J]. 基础医学与临床, 2019, 39(3): 321-325
作者姓名:杨蕙  柳卓  孟盼  杜青  王宇红  刘检  杨琴
作者单位:湖南中医药大学第一附属医院 中心实验室,湖南 长沙,410007;湖南中医药大学 湖南省中药粉体与创新药物省部共建国家重点实验室培育基地,湖南 长沙,410208;湖南省中医药研究院,湖南 长沙,410006
基金项目:国家自然科学基金;湖南省教育厅优秀青年项目;湖南省教育厅一般项目
摘    要:目的观察腺苷A1受体(A1R)激动剂对糖尿病并发抑郁症大鼠学习记忆功能的影响。方法将大鼠分为对照组、模型组、二甲双胍(Met)组[Met组:灌胃给予二甲双胍(0.18 g/kg) 28 d]和二甲双胍联合腺苷A1受体激动剂(Met+CPA)干预组[Met+CPA组:灌胃给予二甲双胍28 d,于第22天开始腹腔注射CPA(1 mg/kg),注射给药7 d]。观察大鼠血糖水平和学习记忆功能;ELISA检测大鼠海马谷氨酸的含量;用免疫组化法和Western blot检测海马谷氨酸转运体GLT-1和脑源性神经营养因子(BDNF)的表达。结果与正常组比较,模型组大鼠血糖含量显著升高(P<0.01);学习和记忆功能明显下降(P<0.01);海马中谷氨酸含量明显升高(P<0.01);而GLT-1和BDNF表达显著下降(P<0.01或P<0.05)。与模型组比较,Met组大鼠仅血糖含量显著下降(P<0.01),其余指标均未见显著变化;而Met+CPA组大鼠血糖含量显著下降(P<0.01),认知功能得到明显的改善(P<0.01),海马中谷氨酸含量显著减少(P<0.01),且GLT-1和BDNF表达显著增加(P<0.01或P<0.05)。结论激活腺苷A1受体可有效改善糖尿病并发抑郁症大鼠的认知功能,这可能与其通过减少谷氨酸释放和增加神经营养作用双途径共同减轻神经元兴奋性毒性有关。

关 键 词:糖尿病并发抑郁症  腺苷A1受体  谷氨酸转运体1  脑源性神经营养因子

Adenosine A1 receptor agonist alleviates the cognitive dysfunction in rats with diabetes mellitus and depression
YANG Hui,LIU Zhuo,MENG Pan,DU Qing,WANG Yu-hong,LIU Jian,YANG Qin. Adenosine A1 receptor agonist alleviates the cognitive dysfunction in rats with diabetes mellitus and depression[J]. Basic Medical Sciences and Clinics, 2019, 39(3): 321-325
Authors:YANG Hui  LIU Zhuo  MENG Pan  DU Qing  WANG Yu-hong  LIU Jian  YANG Qin
Affiliation:(Central Laboratory, the First Affiliated Hospital, Hunan University of Chinese Medicine, Changsha 410007;Key Laboratory of Chinese Materia Medica Power and Innovation Drugs Established by Provincial and Ministry, Hunan University of Chinese Medicine, Changsha 410208;Hunan Provincial Institute of Traditional Chinese Medicine, Changsha 410006, China)
Abstract:Objective To investigate the effect of adenosine A1 receptor (A1R) agonist on learning and memory function of diabetic rats with depression. Methods The rats were divided into control group, model group and metformin(Met)group (0.18 g/kg Metformin was given by ig. for 28 days) and metformin plus adenosine A1 receptor agonist (Met+CPA) intervention group (metformin was given by ig, and then the CPA was intraperitoneally injected at 1 mg/kg from day 22 and administered for 7 days). The blood glucose and learning/ memory function in rats were observed. Then the concentration of glutamate in hippocampus was detected by ELISA. At last, the expression of GLT-1 and BDNF in hippocampus were detected by immunohistochemistry and Western blot. Results Compared with the normal group, the content of blood glucose and the learning and memory function of the model group were significantly decreased( P <0.01). In addition, the concentration of glutamate in hippocampus was significantly increased ( P < 0.01), while the expressions of GLT-1 and BDNF were significantly decreased( P <0.01, P <0.05). Compared with the model group, only the blood glucose level decreased significantly in Met group ( P <0.01) with other indexes did not change significantly. However, there was found that the levels of glucose in blood and glutamate in hippocampus were decreased significantly in Met + CPA group( P <0.01). Furthermore, the cognitive function was significantly improved and the expression of GLT-1 and BDNF was increased( P <0.01, P <0.05). Conclusions Activation of adenosine A1 receptor can effectively improve the cognitive function of diabetic rats with depression, which may be related to its anti-neurotoxicity by reducing the glutamate release and increasing neuronal nutrition function.
Keywords:diabetes mellitus with depression  adenosine A1receptor  glial glutamate transporter-1  brain derived neurotrophic factor
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号